Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proteus species surface antigens are a diverse collection of molecules found on the outer surface of bacteria within the Proteus genus, most notably Proteus mirabilis. These antigens include lipopolysaccharides (O-antigens), flagella (H-antigens), and various fimbriae or pili, such as mannose-resistant/Proteus-like (MR/P) fimbriae (Schaffer & Pearson, 2015). Biologically, these structures are essential for the organism's characteristic swarming motility and its ability to adhere to host tissues and medical devices, facilitating the formation of persistent biofilms (Armbruster et al., 2018). In human disease, these antigens are primary targets of the immune response during complicated urinary tract infections and are involved in the pathogenesis of struvite kidney stones (Norsworthy & Pearson, 2017). They are currently being investigated as primary targets for the development of vaccines and monoclonal antibodies aimed at preventing colonization in high-risk patients, such as those with long-term catheterization (Scavone et al., 2016). Furthermore, certain Proteus antigens have been hypothesized to play a role in the etiology of rheumatoid arthritis through molecular mimicry with host proteins like HLA-DRB1 (Rashid & Ebringer, 2012). Therapeutic strategies targeting these antigens aim to disrupt the initial stages of infection, such as attachment and colonization, rather than relying solely on bactericidal activity. Challenges in targeting these antigens include the high degree of antigenic variation among different Proteus strains and the potential for cross-reactivity with host tissues.
Induction of mucosal and systemic antibodies (IgA and IgG) that inhibit bacterial fimbrial-mediated adhesion and flagellar-mediated motility (Scavone et al., 2016).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteus species surface antigens.